Home page

Hepatitis B Vaccine Family

Hepatitis B Vaccine Family

In 2010, Developed 60μg Recombinant Hepatitis B vaccine (Saccharomyces cerevisiae);
In 2011, Reescalation of hepatitis B vaccine dose: 10μg in children and 20μg in adults;
In 2023, Kangtai Recombinant Hepatitis B vaccine (Saccharomyces cerevisiae) produced more than 1.4 billion doses.

10μg Recombinant Hepatitis B Vaccine (Saccharomyces cerevisiae)

【Active constituent】	Hepatitis B surface antigen．
【Strengths】	0.5ml per container. 0.5 ml per single human dose containing 10 μg of HBsAg．
【Eligibles】	Hepatitis B susceptible populations aged below 16 years, especially newborns whose mother has positive HBsAg and/or HBeAg result.
【Shelf Life】	36 Months

20μg Recombinant Hepatitis B Vaccine (Saccharomyces cerevisiae)

National "12th Five-Year Plan" Major Science and Technology Special Projects;

Certificate of National Key New Products.

【Active constituent】	Hepatitis B surface antigen．
【Strengths】	1.0ml per container．1.0 ml per single human dose containing 20 μg of HBsAg．
【Eligibles】	Hepatitis B susceptible populations aged 16 years and above.
【Shelf Life】	36 Months

60μg Recombinant Hepatitis B Vaccine (Saccharomyces cerevisiae)

【Active constituent】	Hepatitis B surface antigen．
【Strengths】	1.0ml per container．1.0 ml per single human dose containing 60 μg of HBsAg．
【Eligibles】	Hepatitis B susceptible populations aged above 16 years and who don’t respond to routine immunization with Hepatitis B vaccine.
【Shelf Life】	36 Months